跳至主要内容
临床试验/IRCT2016103130572N1
IRCT2016103130572N1已完成未知

The effects of a reduced-sodium, high-potassium salt substitute on hypertensive and normal population of Baharlou Clinic clients, Tehran, Iran at 2016-2017

Research Deputy of Medicine Faculty, Tehran Universiy of Medical Sciences0 个研究点目标入组 250 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 years 至 65 years(—)
性别
All

入选标准

  • Inclusion Criteria: Age 25-65; Blood Pressure equal to or greater than 140 Systolic or 90 Diastolic in three measurements in two settings or consuming an anti-hypertensive drug; Cooperative with consuming salt for 3 months

排除标准

  • Abnormal Serum Creatinine; Abnormal Serum Urea; Consuming medications: Digoxin, Lithium, K-Sparing Diuretics; Acute or Severe Cardiovascular Disease; Psychotic Disorders; Eating fast-foods or take-away foods or going to restaurant more than once a week

研究者

发起方
Research Deputy of Medicine Faculty, Tehran Universiy of Medical Sciences

相似试验